Europe Lung Cancer Screening Software Market to 2032

Overview

The Europe Lung Cancer Screening Software Market is expected to reach a 47.09 USD Million by 2032 and is projected to grow at a CAGR of 35.81% from 2025 to 2032.

Revenue, 2024 (USD Million)

11.20

Forecast, 2032 (USD Million)

47.09

CAGR, 2024 - 2032

35.81%

Report Coverage

Europe

Europe Lung Cancer Screening Software Market 2018-2032 USD Million

Europe Lung Cancer Screening Software Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 11.20 USD Million
Projected Market Size (2032): 47.09 USD Million
CAGR (2025-2032): 35.81%

Key Findings of Europe Lung Cancer Screening Software Market

The Europe Lung Cancer Screening Software Market was valued at 11.20 USD Million in 2024.
The Europe Lung Cancer Screening Software Market is likely to grow at a CAGR of 35.81% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Institutional in Purchase Mode Segment accounted for the largest share of the market with a revenue of 8.87 USD Million
The fastest growing segment Nodule Management Software in Product Segment grew Fastest with a CAGR of 39.75% during the forecast period from 2024 to 2032.

Europe Lung Cancer Screening Software Market Scope

Europe Lung Cancer Screening Software Market Segmentation & Scope

End User

Others
Ambulatory Surgical Centers
Hospitals
Oncology Centers

Distribution Channel

Third Party Distributor
Direct Tenders

Application

Small Cell Lung Cancer (SCLC)
Non-Small Cell Lung Cancer (NSCLC)

Platform

Integrated
Standalone

Purchase Mode

Individual
Institutional

Mode of Delivery

Web Based Solutions1
On-Premise Solutions1
Cloud Based Solutions1

Product

Audit Log Tracking
Practice Management
Screening PACs
Statistical Audit Reporting
Pathology and Cancer Staging
Lung Nodule Computer Aided Detection
Patient Coordination and Workflow
Data Collection and Reporting
Nodule Management Software
Lung Cancer Screening Patient Management Software
Lung Cancer Screening Radiology Solution

Type

Traditional Screening
Computer-Assisted Screening

Europe Lung Cancer Screening Software Market Data Coverage Insights

Study Period	2024-2032
Base Year	2019
Unit	Revenue in USD Million
Market Value in 2024	11.20 USD Million
Market Value in 2032	47.09 USD Million
CAGR (2025-2032)	35.81%
Historic Data	2016-2023
Market Segments Covered	End User,Distribution Channel,Application,Platform,Purchase Mode,Mode of Delivery,Product,Type

Regional Insights:

Leading Market (2024-2032): Europe, leading in terms of revenue 11.20 USD Million in 2024
- Key Country: Germany, leading in terms of revenue with value of 3.04 USD Million in 2024.

Segments and Scope

Europe Lung Cancer Screening Software Market to 2032, By End User
- Oncology Centers is the largest segment in Europe Lung Cancer Screening Software Market to 2032 with a revenue of 7.65 USD Million in the year 2024.
- Oncology Centers is the Fastest growing segment in Europe Lung Cancer Screening Software Market to 2032 with a Growth rate of 38.22 % in forecast period 2025-2032.
Europe Lung Cancer Screening Software Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Europe Lung Cancer Screening Software Market to 2032 with a revenue of 7.66 USD Million in the year 2024.
- Direct Tenders is the Fastest growing segment in Europe Lung Cancer Screening Software Market to 2032 with a Growth rate of 37.68 % in forecast period 2025-2032.
Europe Lung Cancer Screening Software Market to 2032, By Application
- Non-Small Cell Lung Cancer (NSCLC) is the largest segment in Europe Lung Cancer Screening Software Market to 2032 with a revenue of 8.06 USD Million in the year 2024.
- Non-Small Cell Lung Cancer (NSCLC) is the Fastest growing segment in Europe Lung Cancer Screening Software Market to 2032 with a Growth rate of 37.43 % in forecast period 2025-2032.
Europe Lung Cancer Screening Software Market to 2032, By Platform
- Standalone is the largest segment in Europe Lung Cancer Screening Software Market to 2032 with a revenue of 7.16 USD Million in the year 2024.
- Integrated is the Fastest growing segment in Europe Lung Cancer Screening Software Market to 2032 with a Growth rate of 34.25 % in forecast period 2025-2032.
Europe Lung Cancer Screening Software Market to 2032, By Purchase Mode
- Institutional is the largest segment in Europe Lung Cancer Screening Software Market to 2032 with a revenue of 8.87 USD Million in the year 2024.
- Institutional is the Fastest growing segment in Europe Lung Cancer Screening Software Market to 2032 with a Growth rate of 36.87 % in forecast period 2025-2032.
Europe Lung Cancer Screening Software Market to 2032, By Mode of Delivery
- Cloud Based Solutions1 is the largest segment in Europe Lung Cancer Screening Software Market to 2032 with a revenue of 5.43 USD Million in the year 2024.
- Web Based Solutions1 is the Fastest growing segment in Europe Lung Cancer Screening Software Market to 2032 with a Growth rate of 36.92 % in forecast period 2025-2032.
Europe Lung Cancer Screening Software Market to 2032, By Product
- Lung Cancer Screening Radiology Solution is the largest segment in Europe Lung Cancer Screening Software Market to 2032 with a revenue of 3.77 USD Million in the year 2024.
- Nodule Management Software is the Fastest growing segment in Europe Lung Cancer Screening Software Market to 2032 with a Growth rate of 35.21 % in forecast period 2025-2032.
Europe Lung Cancer Screening Software Market to 2032, By Type
- Computer-Assisted Screening is the largest segment in Europe Lung Cancer Screening Software Market to 2032 with a revenue of 8.14 USD Million in the year 2024.
- Computer-Assisted Screening is the Fastest growing segment in Europe Lung Cancer Screening Software Market to 2032 with a Growth rate of 37.37 % in forecast period 2025-2032.

Europe Lung Cancer Screening Software Market Company Share Analysis

Company Name
Medtronic
Oncocyte Corporation
Nuance Communications, Inc.
Koninklijke Philips N.V.
Thynk Health

Europe Lung Cancer Screening Software Market Geographical Sales Distribution, 2018-2032 USD Million

Europe Lung Cancer Screening Software Market Company Profiling

Industry Related Reports

Asia-Pacific Breast Lesion Localization Methods Market

Europe Breast Lesion Localization Methods Market

North America Breast Lesion Localization Methods Market

Middle East & Africa Breast Lesion Localization Methods Market

South America Breast Lesion Localization Methods Market

Australia Breast Lesion Localization Methods Market

Belgium Breast Lesion Localization Methods Market

Brazil Breast Lesion Localization Methods Market

Canada Breast Lesion Localization Methods Market

China Breast Lesion Localization Methods Market

Frequently Asked Questions

What are the primary segments covered in the Europe Lung Cancer Screening Software Market?

The Europe Lung Cancer Screening Software Market is segmented based on Segmentation End User,Distribution Channel,Application,Platform,Purchase Mode,Mode of Delivery,Product,Type.

What is the current market size of the Europe Lung Cancer Screening Software Market?

Europe Lung Cancer Screening Software Market was valued at USD 11.20(Revenue in USD Million) in 2019.

What is the expected growth rate of the Europe Lung Cancer Screening Software Market?

Europe Lung Cancer Screening Software Market is projected to grow at a CAGR of 35.81% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Europe Lung Cancer Screening Software Market?

The Institutional segment is expected to dominate the Europe Lung Cancer Screening Software Market, holding a largest market share of 8.87 USD Million in 2024